Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.

[1]  Thomas Höfer,et al.  Disparate Individual Fates Compose Robust CD8+ T Cell Immunity , 2013, Science.

[2]  D. Busch,et al.  The smallest unit: effector and memory CD8+ T cell differentiation on the single cell level , 2013, Front. Immun..

[3]  P. Hari,et al.  Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  R. Storb,et al.  Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. , 2012, Blood.

[5]  P. Hari,et al.  Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  J. P. McCoy,et al.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  M. Leppert,et al.  Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. , 2010, Blood.

[8]  J. Wagner,et al.  Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II–III trial (T-cell depletion trial) , 2010, Bone Marrow Transplantation.

[9]  J. Wagner,et al.  The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  Michael J. Bevan,et al.  The precursors of memory: models and controversies , 2009, Nature Reviews Immunology.

[11]  T. Nomura,et al.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. , 2009, Immunity.

[12]  D. Jain,et al.  Central Memory CD8+ T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia1 , 2009, The Journal of Immunology.

[13]  J. Zaia,et al.  Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. , 2008, Blood.

[14]  D. Jain,et al.  Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. , 2008, Blood.

[15]  D. Lilleri,et al.  Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection , 2008, Haematologica.

[16]  R. Gress,et al.  46: Androgen Withdrawal Modulates Thymopoiesis by Inducing Thymic Epithelial Cell Proliferation and Increasing Precursor Niche , 2008 .

[17]  Mike Gough,et al.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. , 2008, The Journal of clinical investigation.

[18]  M. Perales,et al.  T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. , 2007, Blood.

[19]  G. Papanicolaou,et al.  Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  G. Papanicolaou,et al.  Predictors for persistent cytomegalovirus reactivation after T‐cell‐depleted allogeneic hematopoietic stem cell transplantation , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[21]  T. George,et al.  Naive and Memory T Cells Induce Different Types of Graft-versus-Host Disease1 , 2007, The Journal of Immunology.

[22]  W. Shlomchik,et al.  Graft-versus-host disease , 2007, Nature Reviews Immunology.

[23]  J. Whitesides,et al.  Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. , 2007, Blood.

[24]  E. Tchilian,et al.  Altered CD45 expression and disease. , 2006, Trends in immunology.

[25]  Andrew J. McMichael,et al.  Molecular Signatures Distinguish Human Central Memory from Effector Memory CD8 T Cell Subsets1 , 2005, The Journal of Immunology.

[26]  J. Wagner,et al.  Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  A. Barrett,et al.  Selective depletion strategies in allogeneic stem cell transplantation. , 2005, Cytotherapy.

[28]  K. Ley,et al.  L‐selectin: mechanisms and physiological significance of ectodomain cleavage , 2005, Journal of cellular and molecular medicine.

[29]  J. Radich,et al.  Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[30]  B. Levine,et al.  Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. , 2004, Blood.

[31]  N. Chao.  Minors come of age: Minor histocompatibility antigens and graft-versus-host disease. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[33]  N. Chao,et al.  Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. , 2004, Blood.

[34]  A. Dejean,et al.  Alloreactive CD4 T lymphocytes responsible for acute and chronic graft‐versus‐host disease are contained within the CD45RChigh but not the CD45RClow subset , 2004, European journal of immunology.

[35]  M. Shlomchik,et al.  Memory CD4+ T cells do not induce graft-versus-host disease. , 2003, The Journal of clinical investigation.

[36]  P. Sondel,et al.  Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease. , 2003, The Journal of clinical investigation.

[37]  S. Endres,et al.  Mature Dendritic Cells Derived from Human Monocytes Within 48 Hours: A Novel Strategy for Dendritic Cell Differentiation from Blood Precursors1 , 2003, The Journal of Immunology.

[38]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[39]  N. Kiyokawa,et al.  Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion. , 2002, Experimental hematology.

[40]  R. Soiffer,et al.  The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. , 2001, Blood.

[41]  P. Moss,et al.  Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics1 , 2001, The Journal of Immunology.

[42]  Susan M. Kaech,et al.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.

[43]  T. Klingebiel,et al.  Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children , 2001, Bone Marrow Transplantation.

[44]  R Storb,et al.  Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. , 2001, The New England journal of medicine.

[45]  F. Sallusto,et al.  Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. , 2000, Science.

[46]  J. Klein,et al.  T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. , 2000, Blood.

[47]  S. L. Silins,et al.  The influence of antiviral T-cell responses on the alloreactive repertoire. , 1999, Immunology today.

[48]  直子 加藤,et al.  Graft-Versus-host Disease , 1999 .

[49]  S. Mackinnon,et al.  Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. , 1999, Blood.

[50]  A. Nademanee,et al.  Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. , 1998, Blood.

[51]  H. Rammensee,et al.  A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  J. Burrows,et al.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.

[53]  U. Verma,et al.  Immune reconstitution following bone marrow transplantation , 1993, Cancer Immunology, Immunotherapy.

[54]  B. Dupont,et al.  Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. , 1986, Blood.

[55]  J. Sprent,et al.  Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow , 1978, The Journal of experimental medicine.

[56]  E. Holler,et al.  Graft-versus-host disease , 2009, The Lancet.

[57]  R H Thurston,et al.  A NEW MOTOR. , 1884, Science.

[58]  D. Jain,et al.  Memory T cells in GVHD and GVL. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[59]  N. Chao.  Memory T cells. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[60]  J. Ferrara,et al.  Pathophysiology of graft-versus-host disease. , 2006, Seminars in hematology.

[61]  T. Hartung,et al.  Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. , 2000, Blood.

[62]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[63]  W. Lee,et al.  Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. , 1994, Clinical immunology and immunopathology.

[64]  H. Deeg,et al.  Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. , 1985, Blood.